CM1, a possible novel activation molecule on human lymphocytes

Dae Y. Hur, Seonghan Kim, Young In Kim, Hye Y. Min, Dae J. Kim, Dong Sup Lee, Dae Ho Cho, Young Il Hwang, Douk H. Hwang, Seong H. Park, Hee K. Ahn, Ka Y. Chang, Yoon B. Kim, Wang J. Lee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

CM1 (centrocyte/-blast marker 1) defined by a mAb developed against concanavalin-A activated PBMC, is expressed specifically on some tonsillar germinal center (GC) B cells. In single flow cytometric analysis, the bone marrow did not express these molecules nor did the PBMC or the thymocytes. The peripheral B lymphocytes showed more than 90% positive, while the peripheral T lymphocytes showed approximately 60% positive at 48 h after activation by PMA/ionomycin, respectively. A western blot analysis and an immunoprecipitation for CM1 showed a band at 70 kDa. Cross-linking of CM1 with anti-CM1 mAb induced apoptosis of the GC B cells (CD38+IgD-). Immunohistochemical staining revealed that the CM1 molecule is distributed over the entire area except the proximal dark zone of the tonsillar germinal centers. These results suggest that the CM1 molecule might be involved in differentiation of the germinal center B cells as one of the novel centrocyte markers. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)95-102
Number of pages8
JournalImmunology Letters
Volume74
Issue number2
DOIs
Publication statusPublished - 2000 Oct 3
Externally publishedYes

Fingerprint

Germinal Center
B-Lymphocytes
Lymphocytes
Immunoglobulin D
Ionomycin
Thymocytes
Concanavalin A
Immunoprecipitation
Bone Marrow
Western Blotting
Apoptosis
Staining and Labeling
T-Lymphocytes

Keywords

  • Activation molecule
  • Apoptosis
  • CM1
  • Human lymphocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Hur, D. Y., Kim, S., Kim, Y. I., Min, H. Y., Kim, D. J., Lee, D. S., ... Lee, W. J. (2000). CM1, a possible novel activation molecule on human lymphocytes. Immunology Letters, 74(2), 95-102. https://doi.org/10.1016/S0165-2478(00)00201-7

CM1, a possible novel activation molecule on human lymphocytes. / Hur, Dae Y.; Kim, Seonghan; Kim, Young In; Min, Hye Y.; Kim, Dae J.; Lee, Dong Sup; Cho, Dae Ho; Hwang, Young Il; Hwang, Douk H.; Park, Seong H.; Ahn, Hee K.; Chang, Ka Y.; Kim, Yoon B.; Lee, Wang J.

In: Immunology Letters, Vol. 74, No. 2, 03.10.2000, p. 95-102.

Research output: Contribution to journalArticle

Hur, DY, Kim, S, Kim, YI, Min, HY, Kim, DJ, Lee, DS, Cho, DH, Hwang, YI, Hwang, DH, Park, SH, Ahn, HK, Chang, KY, Kim, YB & Lee, WJ 2000, 'CM1, a possible novel activation molecule on human lymphocytes', Immunology Letters, vol. 74, no. 2, pp. 95-102. https://doi.org/10.1016/S0165-2478(00)00201-7
Hur, Dae Y. ; Kim, Seonghan ; Kim, Young In ; Min, Hye Y. ; Kim, Dae J. ; Lee, Dong Sup ; Cho, Dae Ho ; Hwang, Young Il ; Hwang, Douk H. ; Park, Seong H. ; Ahn, Hee K. ; Chang, Ka Y. ; Kim, Yoon B. ; Lee, Wang J. / CM1, a possible novel activation molecule on human lymphocytes. In: Immunology Letters. 2000 ; Vol. 74, No. 2. pp. 95-102.
@article{117834a17558403b9ec67410dc4ec110,
title = "CM1, a possible novel activation molecule on human lymphocytes",
abstract = "CM1 (centrocyte/-blast marker 1) defined by a mAb developed against concanavalin-A activated PBMC, is expressed specifically on some tonsillar germinal center (GC) B cells. In single flow cytometric analysis, the bone marrow did not express these molecules nor did the PBMC or the thymocytes. The peripheral B lymphocytes showed more than 90{\%} positive, while the peripheral T lymphocytes showed approximately 60{\%} positive at 48 h after activation by PMA/ionomycin, respectively. A western blot analysis and an immunoprecipitation for CM1 showed a band at 70 kDa. Cross-linking of CM1 with anti-CM1 mAb induced apoptosis of the GC B cells (CD38+IgD-). Immunohistochemical staining revealed that the CM1 molecule is distributed over the entire area except the proximal dark zone of the tonsillar germinal centers. These results suggest that the CM1 molecule might be involved in differentiation of the germinal center B cells as one of the novel centrocyte markers. (C) 2000 Elsevier Science B.V.",
keywords = "Activation molecule, Apoptosis, CM1, Human lymphocytes",
author = "Hur, {Dae Y.} and Seonghan Kim and Kim, {Young In} and Min, {Hye Y.} and Kim, {Dae J.} and Lee, {Dong Sup} and Cho, {Dae Ho} and Hwang, {Young Il} and Hwang, {Douk H.} and Park, {Seong H.} and Ahn, {Hee K.} and Chang, {Ka Y.} and Kim, {Yoon B.} and Lee, {Wang J.}",
year = "2000",
month = "10",
day = "3",
doi = "10.1016/S0165-2478(00)00201-7",
language = "English",
volume = "74",
pages = "95--102",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - CM1, a possible novel activation molecule on human lymphocytes

AU - Hur, Dae Y.

AU - Kim, Seonghan

AU - Kim, Young In

AU - Min, Hye Y.

AU - Kim, Dae J.

AU - Lee, Dong Sup

AU - Cho, Dae Ho

AU - Hwang, Young Il

AU - Hwang, Douk H.

AU - Park, Seong H.

AU - Ahn, Hee K.

AU - Chang, Ka Y.

AU - Kim, Yoon B.

AU - Lee, Wang J.

PY - 2000/10/3

Y1 - 2000/10/3

N2 - CM1 (centrocyte/-blast marker 1) defined by a mAb developed against concanavalin-A activated PBMC, is expressed specifically on some tonsillar germinal center (GC) B cells. In single flow cytometric analysis, the bone marrow did not express these molecules nor did the PBMC or the thymocytes. The peripheral B lymphocytes showed more than 90% positive, while the peripheral T lymphocytes showed approximately 60% positive at 48 h after activation by PMA/ionomycin, respectively. A western blot analysis and an immunoprecipitation for CM1 showed a band at 70 kDa. Cross-linking of CM1 with anti-CM1 mAb induced apoptosis of the GC B cells (CD38+IgD-). Immunohistochemical staining revealed that the CM1 molecule is distributed over the entire area except the proximal dark zone of the tonsillar germinal centers. These results suggest that the CM1 molecule might be involved in differentiation of the germinal center B cells as one of the novel centrocyte markers. (C) 2000 Elsevier Science B.V.

AB - CM1 (centrocyte/-blast marker 1) defined by a mAb developed against concanavalin-A activated PBMC, is expressed specifically on some tonsillar germinal center (GC) B cells. In single flow cytometric analysis, the bone marrow did not express these molecules nor did the PBMC or the thymocytes. The peripheral B lymphocytes showed more than 90% positive, while the peripheral T lymphocytes showed approximately 60% positive at 48 h after activation by PMA/ionomycin, respectively. A western blot analysis and an immunoprecipitation for CM1 showed a band at 70 kDa. Cross-linking of CM1 with anti-CM1 mAb induced apoptosis of the GC B cells (CD38+IgD-). Immunohistochemical staining revealed that the CM1 molecule is distributed over the entire area except the proximal dark zone of the tonsillar germinal centers. These results suggest that the CM1 molecule might be involved in differentiation of the germinal center B cells as one of the novel centrocyte markers. (C) 2000 Elsevier Science B.V.

KW - Activation molecule

KW - Apoptosis

KW - CM1

KW - Human lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0034601875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034601875&partnerID=8YFLogxK

U2 - 10.1016/S0165-2478(00)00201-7

DO - 10.1016/S0165-2478(00)00201-7

M3 - Article

VL - 74

SP - 95

EP - 102

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 2

ER -